Nicotine Replacement Therapy Market Trends

Nicotine Replacement Therapy Market Trends

• Smoking is a well-established risk factor for various types of cancer, including lung, throat, and pancreatic cancer. For instance, according to the Centers for Disease Control and Prevention (CDCP), in 2023, cigarette smoking is considered as number one risk factor for lung cancer, and has been linked to about 80% to 90% of lung cancer deaths in the U.S. alone. Similarly, as per the American Cancer Society Journal, 1,03,371 cases of lung cancer were diagnosed in 2022 in the U.S. Thus, as awareness of the link between tobacco use and cancer grows, individuals are increasingly motivated to quit smoking to improve their treatment outcomes and overall health.
   
• Additionally, cancer treatment centers and healthcare institutions offer smoking cessation programs specifically designed for individuals diagnosed with cancer. Nicotine replacement therapy play a crucial role in these programs to help patients quit smoking before or after their cancer diagnosis.
   

However, side effects may lead to reduced patient compliance and adherence to NRT regimens. If individuals experience discomfort or undesirable effects, they may be less likely to continue using NRT products as recommended.